Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-8-10
pubmed:abstractText
Chemoradiotherapy combined with 5-fluorouracil and cisplatin have been effective for the treatment of advanced esophageal cancer, but superior treatments are needed. We prospectively analyzed the efficacy of concurrent chemoradiotherapy using oral fluoropyrimidine (S-1) and cisplatin for the treatment of advanced esophageal cancer.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0385-0684
pubmed:author
pubmed:issnType
Print
pubmed:volume
33 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
224-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16898007-Aged, pubmed-meshheading:16898007-Aged, 80 and over, pubmed-meshheading:16898007-Anemia, pubmed-meshheading:16898007-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16898007-Cisplatin, pubmed-meshheading:16898007-Combined Modality Therapy, pubmed-meshheading:16898007-Drug Administration Schedule, pubmed-meshheading:16898007-Drug Combinations, pubmed-meshheading:16898007-Esophageal Neoplasms, pubmed-meshheading:16898007-Female, pubmed-meshheading:16898007-Humans, pubmed-meshheading:16898007-Male, pubmed-meshheading:16898007-Middle Aged, pubmed-meshheading:16898007-Neoplasm Staging, pubmed-meshheading:16898007-Oxonic Acid, pubmed-meshheading:16898007-Prospective Studies, pubmed-meshheading:16898007-Radiotherapy Dosage, pubmed-meshheading:16898007-Survival Rate, pubmed-meshheading:16898007-Tegafur, pubmed-meshheading:16898007-Thrombocytopenia
pubmed:year
2006
pubmed:articleTitle
[Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
pubmed:affiliation
Dept. of Gastroenterology, Nagoya Medical Center, Japan.
pubmed:publicationType
Journal Article, English Abstract, Clinical Trial, Phase II, Clinical Trial, Phase I